Company / Book Value per Share
Viking Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.728
FY2025
5-year range
$1.857 / $8.793
FY2021-FY2025
Trend
-34.9%
vs FY2024
Sector context
#102 of 209
Health Care
What the data says
At $5.728, Viking Therapeutics, Inc.'s book value per share ranks #102 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $0.647 in FY2017 to $8.793 in FY2024.
Based on SEC 10-K filings.
$5.728 in FY2025 with a 5-year CAGR of +11.2%.
Improved from $4.452 to $5.728 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +45.6%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#102 of 209 in Health CareTop 49% of 209This company $5.728 Sector average $189.406
▼
-97.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, book value per share decreased 34.9% year-over-year.
- Ranks #102 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.728 | -34.9% |
| FY2024 | $8.793 | +97.5% |
| FY2023 | $4.452 | +139.7% |
| FY2022 | $1.857 | -32.6% |
| FY2021 | $2.757 | -18.3% |
| FY2020 | $3.374 | -12.6% |
| FY2019 | $3.863 | -53.5% |
| FY2018 | $8.313 | +1185.7% |
| FY2017 | $0.647 | -22.2% |
| FY2016 | $0.831 | -42.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026